Board meeting on November 4, 2026 to consider unaudited September 2026 quarter and half-year results
Board meeting on Wednesday, November 4, 2026.
- Board Meeting Date
- Wednesday, November 4, 2026
- Results Period
- three and six months ended 30th September 2026
- Trading Window Closure
- October 1, 2026 till 48 hours after the announcement of financial results, i.e. upto November 6, 2026
Board meeting date
The company has informed the exchanges that a meeting of its Board of Directors will be held on Wednesday, November 4, 2026. This is further to its earlier letter dated 24th September 2026.
What the Board will consider
- Approval of the unaudited financial results (Standalone and Consolidated)
- The results are for the period of three and six months ended 30th September 2026
What these results represent
The three-month figure is the quarter ended September 2026. The six-month figure is the first half of the financial year, combining the June and September quarters. The numbers will be presented in standalone form (the company on its own) and consolidated form (the company together with its subsidiaries and other group entities).
Trading window closure
- The trading window continues to remain closed for promoters, directors, other connected persons and designated employees of the company from October 1, 2026
- It stays closed till 48 hours after the announcement of the financial results, i.e. upto November 6, 2026
- During this window these groups are restricted from trading in the company's shares
This closure is a periodic measure linked to the announcement of results, when people who may have early access to the numbers are restricted from dealing in the shares.
Why this is relevant to a retail investor
This is a notice of a scheduled event: it tells you when the September 2026 quarter and half-year results will be taken up for approval. The results themselves are considered at that meeting.
Also from Apollo Hospitals Enterprise
Technical analyst advised reducing Apollo Hospitals position on a short-term view after recent correction from record highs
12 Oct 2026
Apollo Hospitals rose about 4% as a clear beneficiary of the cancer drug trade margin cap being less severe than feared
9 Oct 2026
Apollo Hospitals stock fell on concerns of possible regulatory scrutiny over hospitals directing patients to in-house pharmacies
6 Oct 2026
More numbers
- Financial results period (first part)three months
- Financial results period (second part)six months
- Trading window closure after results announcement48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.